Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
QuintilesIMS
Medtronic
Fuji
Colorcon
Dow
Baxter
Healthtrust
Mallinckrodt

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,379,454

« Back to Dashboard

Summary for Patent: 4,379,454
Title: Dosage for coadministering drug and percutaneous absorption enhancer
Abstract:A dosage form that coadministers a drug and a percutaneous absorption enhancer to a defined area of the skin. The dosage form comprises a body that contains supplies of drug and enhancer and has a basal surface that contacts the area of skin and transmits the drug and enhancer to the area for absorption thereby. The drug is provided to the basal surface at a rate at least as great as the rate at which the skin is able to absorb the drug whereas the enhancer is via a rate controlling means at a substantially constant rate that increases the permeability of the treated area of skin to the drug to a level at which the drug is absorbed at a therapeutically effective rate.
Inventor(s): Campbell; Patricia S. (Palo Alto, CA), Chandrasekaran; Santosh K. (Palo Alto, CA)
Assignee: ALZA Corporation (Palo Alto, CA)
Application Number:06/235,068
Patent Claim Types:
see list of patent claims
Dosage form; Composition; Use;

Drugs Protected by US Patent 4,379,454

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,379,454

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 547007 ➤ Try a Free Trial
Australia 565178 ➤ Try a Free Trial
Australia 4502085 ➤ Try a Free Trial
Australia 7954582 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Mallinckrodt
McKinsey
US Army
Cerilliant
Fuji
McKesson
Cantor Fitzgerald
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.